Intellia Therapeutics Inc buy Chardan Capital
Start price
07.08.23
/
50%
€35.98
Target price
07.08.24
€97.28
Performance (%)
-45.29%
End price
08.08.24
€19.69
Summary
This prediction ended on 08.08.24 with a price of €19.69. Massive losses of -45.29% were the result for the BUY prediction by Chardan_Capital. Chardan_Capital has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 5.993% | 5.993% | 12.432% |
| iShares Core DAX® | -1.875% | 2.861% | 18.863% |
| iShares Nasdaq 100 | -2.177% | 0.048% | 3.956% |
| iShares Nikkei 225® | -0.867% | 6.987% | 21.062% |
| iShares S&P 500 | -1.253% | 1.248% | 2.246% |
Comments by Chardan_Capital for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $107.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.69
28.02.25
28.02.25
€65.29
28.02.26
28.02.26
4.28%
12:13
12:13
Stopped prediction by Chardan_Capital for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€12.31
27.10.25
27.10.25
€41.25
27.10.26
27.10.26
-15.52%
12:13
12:13
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.60
09.05.25
09.05.25
€60.64
09.05.26
09.05.26
34.87%
12:13
12:13
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€13.46
18.11.24
18.11.24
€86.10
18.11.25
18.11.25
-46.48%
19.11.25
19.11.25